Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Recurrent Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2